[The glutaminergic system (II): the physiopathological, clinical and therapeutic aspects].
Marco-Igual
M
M
Unidad de Neurología, Consorci Hospitalari del Parc Taulí, Sabadell, Barcelona.
D000818:Animals; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000503:physiopathology; D009422:Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology; D017470:Receptors, Glutamate / Q000187:drug effects / Q000502:physiology*
D018690:Excitatory Amino Acid Agonists; D018691:Excitatory Amino Acid Antagonists; D017470:Receptors, Glutamate